Imaging Biomarker Market Report: Trends, Forecast and Competitive Analysis to 2030
It will take 2-3 business days to deliver the report upon receipt the order if any customization is not there.
Imaging Biomarker Trends and Forecast
The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Imaging Biomarker by Segment
The study includes a forecast for the global imaging biomarker by technology, application, and region.
Imaging Biomarker Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies imaging biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the imaging biomarker companies profiled in this report include-
Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.
Disease diagnosis will remain the largest segment due to their ability to enable the characterization of patient populations to which new drugs reach intended targets.
North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.
Features of the Global Imaging Biomarker Market
Market Size Estimates: Imaging biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Imaging biomarker market size by technology, application, and region in terms of value ($B).
Regional Analysis: Imaging biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, applications, and regions for the imaging biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the imaging biomarker market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the imaging biomarker market size?
Answer: The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030.
Q.2 What is the growth forecast for imaging biomarker market?
Answer: The global imaging biomarker market is expected to grow with a CAGR of 14.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the imaging biomarker market?
Answer: The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.
Q4. What are the major segments for imaging biomarker market?
Answer: The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets.
Q5. Who are the key imaging biomarker market companies?
Answer: Some of the key imaging biomarker companies are as follows:
Answer: Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.
Q7. In imaging biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the imaging biomarker market by technology (positron emission tomography, ultrasound, magnetic resonance imaging,computed tomography, single-photon emission computed tomography, and others) application (personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis, forensic applications, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Imaging Biomarker Market, Imaging Biomarker Market Size, Imaging Biomarker Market Growth, Imaging Biomarker Market Analysis, Imaging Biomarker Market Report, Imaging Biomarker Market Share, Imaging Biomarker Market Trends, Imaging Biomarker Market Forecast, Imaging Biomarker Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
Imaging Biomarker Trends and Forecast
The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets. The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030 with a CAGR of 14.6% from 2024 to 2030. The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Imaging Biomarker by Segment
The study includes a forecast for the global imaging biomarker by technology, application, and region.
Imaging Biomarker Market by Technology [Shipment Analysis by Value from 2018 to 2030]:
- Positron Emission Tomography
- Ultrasound
- Magnetic Resonance Imaging
- Computed Tomography
- Single-Photon Emission Computed Tomography
- Others
- Personalized Medicines
- Drug Discovery and Development
- Molecular Diagnostics
- Drug Formulation
- Disease Diagnosis
- Forensic Applications
- Others
- North America
- Europe
- Asia Pacific
- The Rest of the World
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies imaging biomarker companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the imaging biomarker companies profiled in this report include-
- Siemens Healthineers
- Icon
- Invicro
- Median Technologies
- Pi Solutions
- Ixico
- Bioxydyn
- Zionexa
- Imabiotech
- Brainomix
Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.
Disease diagnosis will remain the largest segment due to their ability to enable the characterization of patient populations to which new drugs reach intended targets.
North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.
Features of the Global Imaging Biomarker Market
Market Size Estimates: Imaging biomarker market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Imaging biomarker market size by technology, application, and region in terms of value ($B).
Regional Analysis: Imaging biomarker market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different technologies, applications, and regions for the imaging biomarker market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the imaging biomarker market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q.1 What is the imaging biomarker market size?
Answer: The global imaging biomarker market is expected to reach an estimated $17.7 billion by 2030.
Q.2 What is the growth forecast for imaging biomarker market?
Answer: The global imaging biomarker market is expected to grow with a CAGR of 14.6% from 2024 to 2030.
Q.3 What are the major drivers influencing the growth of the imaging biomarker market?
Answer: The major drivers for this market are the rise in cases of chronic cases, technological breakthroughs like virtualization of imaging biomarkers and big data technologies, and increasing inclination towards healthcare across the globe.
Q4. What are the major segments for imaging biomarker market?
Answer: The future of the global imaging biomarker market looks promising with opportunities in the personalized medicine, drug discovery and development, molecular diagnostic, drug formulation, disease diagnosis, and forensic markets.
Q5. Who are the key imaging biomarker market companies?
Answer: Some of the key imaging biomarker companies are as follows:
- Siemens Healthineers
- ICON
- Invicro
- Median Technologies
- PI Solutions
- IXICO
- Bioxydyn
- Zionexa
- Imabiotech
- BRAINOMIX
Answer: Lucintel forecasts that magnetic resonance imaging will remain the largest segment over the forecast period as it aids in detecting spinal lesions, cancers, and vascular and brain disorders.
Q7. In imaging biomarker market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing awareness of the disease and growing technological advancements in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the imaging biomarker market by technology (positron emission tomography, ultrasound, magnetic resonance imaging,computed tomography, single-photon emission computed tomography, and others) application (personalized medicines, drug discovery and development, molecular diagnostics, drug formulation, disease diagnosis, forensic applications, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Imaging Biomarker Market, Imaging Biomarker Market Size, Imaging Biomarker Market Growth, Imaging Biomarker Market Analysis, Imaging Biomarker Market Report, Imaging Biomarker Market Share, Imaging Biomarker Market Trends, Imaging Biomarker Market Forecast, Imaging Biomarker Companies, write Lucintel analyst at email: [email protected]. We will be glad to get back to you soon.
1. EXECUTIVE SUMMARY
2. GLOBAL IMAGING BIOMARKER MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Imaging Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Imaging Biomarker Market by Technology
3.3.1: Positron Emission Tomography
3.3.2: Ultrasound
3.3.3: Magnetic Resonance Imaging
3.3.4: Computed Tomography
3.3.5: Single-Photon Emission Computed Tomography
3.3.6: Others
3.4: Global Imaging Biomarker Market by Application
3.4.1: Personalized Medicines
3.4.2: Drug Discovery and Development
3.4.3: Molecular Diagnostics
3.4.4: Drug Formulation
3.4.5: Disease Diagnosis
3.4.6: Forensic Applications
3.4.7: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Imaging Biomarker Market by Region
4.2: North American Imaging Biomarker Market
4.2.2: North American Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.3: European Imaging Biomarker Market
4.3.1: European Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.3.2: European Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.4: APAC Imaging Biomarker Market
4.4.1: APAC Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.4.2: APAC Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.5: ROW Imaging Biomarker Market
4.5.1: ROW Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.5.2: ROW Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Othersers
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Imaging Biomarker Market by Technology
6.1.2: Growth Opportunities for the Global Imaging Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Imaging Biomarker Market by Region
6.2: Emerging Trends in the Global Imaging Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Imaging Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Imaging Biomarker Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Siemens Healthineers
7.2: ICON
7.3: Invicro
7.4: Median Technologies
7.5: PI Solutions
7.6: IXICO
7.7: Bioxydyn
7.8: Zionexa
7.9: Imabiotech
7.10: BRAINOMIX
2. GLOBAL IMAGING BIOMARKER MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Imaging Biomarker Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Imaging Biomarker Market by Technology
3.3.1: Positron Emission Tomography
3.3.2: Ultrasound
3.3.3: Magnetic Resonance Imaging
3.3.4: Computed Tomography
3.3.5: Single-Photon Emission Computed Tomography
3.3.6: Others
3.4: Global Imaging Biomarker Market by Application
3.4.1: Personalized Medicines
3.4.2: Drug Discovery and Development
3.4.3: Molecular Diagnostics
3.4.4: Drug Formulation
3.4.5: Disease Diagnosis
3.4.6: Forensic Applications
3.4.7: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Imaging Biomarker Market by Region
4.2: North American Imaging Biomarker Market
4.2.2: North American Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.3: European Imaging Biomarker Market
4.3.1: European Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.3.2: European Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.4: APAC Imaging Biomarker Market
4.4.1: APAC Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.4.2: APAC Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Others
4.5: ROW Imaging Biomarker Market
4.5.1: ROW Imaging Biomarker Market by Technology: Positron Emission Tomography, Ultrasound, Magnetic Resonance Imaging, Computed Tomography, Single-Photon Emission Computed Tomography, and Others
4.5.2: ROW Imaging Biomarker Market by Application: Personalized Medicines, Drug Discovery and Development, Molecular Diagnostics, Drug Formulation, Disease Diagnosis, Forensic Applications, and Othersers
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Imaging Biomarker Market by Technology
6.1.2: Growth Opportunities for the Global Imaging Biomarker Market by Application
6.1.3: Growth Opportunities for the Global Imaging Biomarker Market by Region
6.2: Emerging Trends in the Global Imaging Biomarker Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Imaging Biomarker Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Imaging Biomarker Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: Siemens Healthineers
7.2: ICON
7.3: Invicro
7.4: Median Technologies
7.5: PI Solutions
7.6: IXICO
7.7: Bioxydyn
7.8: Zionexa
7.9: Imabiotech
7.10: BRAINOMIX
